These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27795359)

  • 1. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Wang Z; Lazinski DW; Camilli A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.
    Leitner DR; Feichter S; Schild-Prüfert K; Rechberger GN; Reidl J; Schild S
    Infect Immun; 2013 Jul; 81(7):2379-93. PubMed ID: 23630951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
    Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.
    Bishop AL; Tarique AA; Patimalla B; Calderwood SB; Qadri F; Camilli A
    J Infect Dis; 2012 Feb; 205(3):412-21. PubMed ID: 22147790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
    Charles RC; Kelly M; Tam JM; Akter A; Hossain M; Islam K; Biswas R; Kamruzzaman M; Chowdhury F; Khan AI; Leung DT; Weil A; LaRocque RC; Bhuiyan TR; Rahman A; Mayo-Smith LM; Becker RL; Vyas JM; Faherty CS; Nickerson KP; Giffen S; Ritter AS; Waldor MK; Xu P; Kováč P; Calderwood SB; Kauffman RC; Wrammert J; Qadri F; Harris JB; Ryan ET
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.
    Schild S; Nelson EJ; Bishop AL; Camilli A
    Infect Immun; 2009 Jan; 77(1):472-84. PubMed ID: 19001078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Mouse Ileal loop Protection against Clinically Isolated Vibrio cholerae Outer Membrane Vesicles as a Vaccine Candidate.
    Sedaghat M; Siadat SD; Shahcheraghi F; Mirabzadeh Ardakani E; Keramati M; Vaziri F; Nojoumi SA
    Arch Razi Inst; 2021 Jan; 75(4):451-461. PubMed ID: 33403840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity.
    Sinha R; Howlader DR; Ta A; Mitra S; Das S; Koley H
    Vaccine; 2017 Jun; 35(28):3534-3547. PubMed ID: 28545924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios.
    Sengupta DK; Sengupta TK; Ghose AC
    FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera: Immunity and Prospects in Vaccine Development.
    Harris JB
    J Infect Dis; 2018 Oct; 218(suppl_3):S141-S146. PubMed ID: 30184117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
    Rijpkema SG; Jansen WH; Gielen H; Guinée PA
    Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one dose experimental cholera vaccine.
    Muse M; Grandjean C; Wade TK; Wade WF
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.
    Schild S; Nelson EJ; Camilli A
    Infect Immun; 2008 Oct; 76(10):4554-63. PubMed ID: 18678672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.